General Information
Revision date
2025-12-22
Product name
TEKNOPAINT ADDITIVE 7901-47 - ANTI SILIKONE/LEVELLING
1.2.1 Relevant identified uses
Paint
Icons in SDS
Company Information
company name
Teknos Group Oy
e-mail address of the competent person responsible for the Safety Data Sheet
Prod-safe@teknos.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H318, H335, H411
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mono-constituent substance
Signal word
Danger
Hazard statements
H315 - Causes skin irritation. H318 - Causes serious eye damage. H335 - May cause respiratory irritation. H411 - Toxic to aquatic life with long lasting effects.
Prevention
P280 - Wear protective gloves. Wear eye or face protection. P273 - Avoid release to the environment.
Response
P391 - Collect spillage. P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Storage
P403 + P233 - Store in a well-ventilated place. Keep container tightly closed.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
Hazardous Ingredients
reaction product of Alcohols, C9-11-iso-, C10-rich, maleic anhydride, ammonium bisulfite and propylene glycol
2.3 Other hazards
Product meets the criteria PBT P B T vPvB vP vB
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mono-constituent substance Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Skin Irrit. 2, H315 Eye Dam. 1, H318 STOT SE 3, H335 Aquatic Chronic 2, H411 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.